Bryn Mawr Capital Management LLC decreased its holdings in shares of Keurig Dr Pepper, Inc (NASDAQ:KDP - Free Report) by 7.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 286,133 shares of the company's stock after selling 23,657 shares during the period. Bryn Mawr Capital Management LLC's holdings in Keurig Dr Pepper were worth $9,791,000 at the end of the most recent reporting period.
Other large investors have also added to or reduced their stakes in the company. ST Germain D J Co. Inc. acquired a new stake in shares of Keurig Dr Pepper in the 1st quarter valued at about $27,000. New Age Alpha Advisors LLC boosted its holdings in Keurig Dr Pepper by 82.8% in the fourth quarter. New Age Alpha Advisors LLC now owns 859 shares of the company's stock worth $28,000 after acquiring an additional 389 shares in the last quarter. Edmond DE Rothschild Holding S.A. bought a new position in Keurig Dr Pepper in the fourth quarter worth approximately $42,000. Continuum Advisory LLC grew its stake in Keurig Dr Pepper by 82.5% in the first quarter. Continuum Advisory LLC now owns 1,332 shares of the company's stock valued at $46,000 after acquiring an additional 602 shares during the period. Finally, Global Trust Asset Management LLC bought a new stake in shares of Keurig Dr Pepper during the first quarter valued at approximately $48,000. Institutional investors and hedge funds own 93.99% of the company's stock.
Keurig Dr Pepper Stock Performance
Shares of NASDAQ KDP traded up $0.47 during midday trading on Wednesday, reaching $33.21. The company's stock had a trading volume of 8,831,003 shares, compared to its average volume of 10,990,698. The stock has a market capitalization of $45.11 billion, a P/E ratio of 30.19, a PEG ratio of 2.52 and a beta of 0.47. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.47 and a quick ratio of 0.31. The firm has a 50 day moving average price of $33.26 and a 200-day moving average price of $33.16. Keurig Dr Pepper, Inc has a 12-month low of $30.12 and a 12-month high of $38.28.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last issued its quarterly earnings results on Thursday, April 24th. The company reported $0.42 EPS for the quarter, topping analysts' consensus estimates of $0.38 by $0.04. The business had revenue of $3.64 billion for the quarter, compared to analyst estimates of $3.57 billion. Keurig Dr Pepper had a return on equity of 10.86% and a net margin of 9.69%. Keurig Dr Pepper's quarterly revenue was up 4.8% compared to the same quarter last year. During the same period last year, the company posted $0.38 earnings per share. As a group, equities analysts predict that Keurig Dr Pepper, Inc will post 1.92 earnings per share for the current year.
Keurig Dr Pepper Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, July 11th. Shareholders of record on Friday, June 27th were paid a $0.23 dividend. This represents a $0.92 dividend on an annualized basis and a yield of 2.77%. The ex-dividend date was Friday, June 27th. Keurig Dr Pepper's payout ratio is 83.64%.
Analyst Ratings Changes
KDP has been the topic of a number of recent research reports. Hsbc Global Res upgraded Keurig Dr Pepper from a "hold" rating to a "strong-buy" rating in a report on Friday, April 25th. Argus assumed coverage on shares of Keurig Dr Pepper in a research note on Wednesday, April 16th. They issued a "buy" rating and a $40.00 price objective on the stock. Piper Sandler upgraded shares of Keurig Dr Pepper from a "neutral" rating to an "overweight" rating and lifted their price objective for the company from $35.00 to $40.00 in a report on Wednesday, April 9th. UBS Group upped their target price on shares of Keurig Dr Pepper from $40.00 to $42.00 and gave the stock a "buy" rating in a report on Thursday, April 17th. Finally, HSBC upgraded Keurig Dr Pepper from a "hold" rating to a "buy" rating and lifted their price target for the company from $36.00 to $42.00 in a research note on Friday, April 25th. Two research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Keurig Dr Pepper presently has a consensus rating of "Moderate Buy" and a consensus target price of $39.92.
Check Out Our Latest Research Report on KDP
Insider Transactions at Keurig Dr Pepper
In related news, insider Mary Beth Denooyer sold 12,000 shares of the company's stock in a transaction that occurred on Tuesday, July 1st. The shares were sold at an average price of $33.64, for a total transaction of $403,680.00. Following the sale, the insider directly owned 94,511 shares in the company, valued at approximately $3,179,350.04. This represents a 11.27% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, VP Angela A. Stephens sold 14,500 shares of the business's stock in a transaction on Wednesday, May 7th. The shares were sold at an average price of $34.24, for a total value of $496,480.00. Following the sale, the vice president owned 62,411 shares in the company, valued at approximately $2,136,952.64. The trade was a 18.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 698,500 shares of company stock valued at $23,580,720 in the last three months. 0.40% of the stock is currently owned by company insiders.
Keurig Dr Pepper Profile
(
Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Read More

Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.